Artwork
iconShare
 
Manage episode 337365584 series 2738732
Content provided by Greg Kubin & Matias Serebrinsky, Greg Kubin, and Matias Serebrinsky. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Greg Kubin & Matias Serebrinsky, Greg Kubin, and Matias Serebrinsky or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
This is part 2 or our 3 part series on microdosing that explore the science, history, and clinical applications. In part 1, we interviewed psychedelic researcher James Fadiman about the fundamentals of microdosing.
In part 2, we wanted to understand the placebo effect. In particular, is it the microdose that makes people feel better or it is a placebo effect? We interviewed Balázs Szigeti PhD, who is a researcher associate at the Centre for Psychedelic Research at Imperial College London. His team conducted the largest placebo-controlled microdosing study in 2020. Balázs unpacks the study and their findings in the episode.
Credits:

Created by Greg Kubin and Matias Serebrinsky
Host: Greg Kubin and Matias Serebrinsky
Produced by Jonathan A. Davis & Zack Frank

Find us at businesstrip.fm
Follow us on Instagram and Twitter!
Theme music by Dorian Love
Additional Music:
Distant Daze by Zack Frank
Zone Out by Daniel Fridell
Links to topics discussed in this episode:
Self-blinding citizen science to explore psychedelic microdosing (Szigeti et al., 2021)
Centre for Psychedelic Research - Imperial College London
Statistical and clinical significance
  continue reading

60 episodes